Home›LONGEVITY & HEALTHSPAN›SGLT2 Inhibitors (Empagliflozin / Canagliflozin)

SGLT2 Inhibitors (Empagliflozin / Canagliflozin)

Evidence: ★★★★☆ · Status: FDA Approved, Off-Label

💡 Did you know? SGLT2-inhibitor diabetes drugs work by making you urinate out excess sugar — and unexpectedly turned out to protect the heart and kidneys.

In plain English

Makes you pee out excess sugar, creating a gentle calorie deficit and metabolic-stress benefit. Strong heart and kidney data; emerging longevity signal.

How it works

Block renal glucose reabsorption transporter SLC5A2 (SGLT2), causing urinary glucose loss, mild caloric deficit, ketone elevation, and reduced senescence/inflammation markers. Canagliflozin extended male-mouse lifespan (ITP).

Molecular target & official sources

SLC5A2 SGLT2 (NCBI Gene) · Empagliflozin (PubChem CID 11949646)

Watch out

Genital yeast infections, rare ketoacidosis, dehydration.

Bottom line

Strong cardiometabolic evidence; increasingly used off-label for aging.

Helps with: Recover Faster · Live Longer · Cardiovascular · Stress & Anxiety

Stacks with

Shares a pathway — often paired with: Omega-3 (EPA/DHA), Rapamycin (Sirolimus), Statins (Atorvastatin/Rosuvastatin), Saffron (Crocus sativus).

Availability & where to buy

Prescription only. Prescription-only — a doctor must prescribe it. Not sold over the counter. (In Singapore: HSA-regulated.)

How it works: the NF-κB / Inflammation pathway →

Compare SGLT2 Inhibitors (Empagliflozin / Canagliflozin)

Common questions

Does SGLT2 Inhibitors (Empagliflozin / Canagliflozin) actually work?

Human-evidence rating: 4 of 5. Strong cardiometabolic evidence; increasingly used off-label for aging.

What are the risks or side effects of SGLT2 Inhibitors (Empagliflozin / Canagliflozin)?

Genital yeast infections, rare ketoacidosis, dehydration.

Is SGLT2 Inhibitors (Empagliflozin / Canagliflozin) legal or approved?

Regulatory status: FDA Approved, Off-Label.